Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
Shigeru KoizumiReiichi DoiUrara AitakeXiaofeng LeiTeruaki IzumiTatsuhiko MoriNaoko ShojiguchiTomonori KawasakiTakashi InozumeAkiko KishiPublished in: The Journal of dermatology (2024)